Anti-gingivitis

"Anti-gingivitis" is not a specific molecular target, such as a receptor or enzyme, but rather a therapeutic indication or pharmacological category used to describe agents that prevent or treat gingivitis. Gingivitis is the earliest stage of periodontal disease, characterized by inflammation of the gums caused by the accumulation of bacterial plaque on the teeth. Drugs and antiseptic agents categorized as anti-gingivitis treatments work primarily by disrupting the dental biofilm or killing the pathogenic bacteria responsible for the inflammatory response. Common agents include chlorhexidine gluconate, stannous fluoride, and various essential oils found in mouthwashes and toothpastes. Because the term refers to a clinical outcome rather than a distinct biological molecule, it is considered an incorrect entry for a specific molecular target database.

Other names

Gingivitis treatmentPlaque control agentGingival health agent

Anti-gingivitis agents typically work by reducing the microbial load in the oral cavity, inhibiting the formation of dental plaque (biofilm), or modulating the host inflammatory response in the gingival tissues.